Stocks and Investing Stocks and Investing
Tue, March 15, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (TWLO) at Buy with Decreased Target to $285 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Rosivach Upgraded (UDR) to Buy on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Eric Beder Maintained (UGRO) at Strong Buy with Increased Target to $14 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (TEAM) at Buy with Decreased Target to $425 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Vijay Kumar Initiated (SYK) at Buy and Held Target at $284 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Kenneth Zener Maintained (TOL) at Sell with Decreased Target to $43 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
David Koning Initiated (TOST) at Buy and Held Target at $25 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Blaine Heck Maintained (STAG) at Buy with Decreased Target to $46 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (SPRB) at Buy with Decreased Target to $9 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (SMAR) at Buy with Decreased Target to $70 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Sophie Karp Maintained (CEG) at Buy with Increased Target to $55 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Eric Beaumont Maintained (AWR) at Sell with Decreased Target to $85 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Ramsey El-Assal Maintained (AVDX) at Buy with Decreased Target to $12 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Schwartz Maintained (ASND) at Buy with Increased Target to $193 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Tazeen Ahmad Upgraded (ASND) to Strong Buy and Increased Target to $161 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (ASND) at Buy with Increased Target to $197 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Philippe Houchois Maintained (ALV) at Strong Buy with Decreased Target to $108 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (BLND) at Buy with Decreased Target to $11 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Gengaro Maintained (BLNK) at Hold with Decreased Target to $30 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Jay Olson Initiated (BIVI) at Buy and Held Target at $90 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Aneesha Sherman Initiated (BURL) at Buy and Held Target at $230 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Alexander Nowak Initiated (BVS) at Strong Buy and Held Target at $30 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Chang Maintained (ADAP) at Hold with Decreased Target to $3 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (ADBE) at Buy with Decreased Target to $625 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Saket Kalia Maintained (ADBE) at Buy with Decreased Target to $540 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Rosivach Maintained (AMT) at Hold with Decreased Target to $257 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Jacob Hughes Maintained (AMPH) at Hold with Increased Target to $32 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (ARCT) at Strong Buy with Decreased Target to $86 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Ramsey El-Assal Maintained (ARBK) at Buy with Decreased Target to $15 on, Mar 15th, 2022
[ 12:00 AM ] - WOPRAI
Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $19 on, Mar 15th, 2022

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $19 on, Mar 15th, 2022


Published on 2024-10-27 20:05:13 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $20 to $19 on, Mar 15th, 2022.

Tejas, nor any peers, have made any analyst calls on AKYA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources